Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Dec, 2019 | Pages:
111 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)
The U.S. gastroenterology ambulatory surgery center market size is anticipated to reach USD 10.8 billion by 2026, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.91% over the forecast period. The growth can be attributed to cost-efficiency, improved patient outcomes, and patient convenience provided by the ambulatory surgery centers. In addition, factors such as rising prevalence of digestive diseases and growing geriatric population are expected to fuel the growth. Establishment and maintenance of hospitals and other healthcare settings are capital-intensive. In addition, high cost of hospitalization associated with inpatient admission has led to increased patient preference for outpatient facilities over hospital visits. The number of ambulatory surgery centers (ASCs) in U.S. has witnessed a surge in the last few years in order to fulfill the growing demand for alternate surgical facilities. Currently, there are more than 9,280 ASCs in U.S. with highest concentration in California, Florida, and Texas. The other segment includes ASCs owned by various joint ventures such as physician-hospital, physician-hospital-corporate, and physician-corporate gastroenterology. The physician-hospital joint-venture ASCs are gaining traction due to better patient outcomes, enhanced productivity, and ownership interest. The rising number of partnerships and acquisitions is a key factor expected to drive the growth of the market. In February 2019, SurgCenter Development entered into an agreement with Surgery Partners to develop new ambulatory surgery centers. Key industry participants among the service provider include Envision Healthcare Corporation; Tenet Healthcare Corporation; Surgery Partners; Community Health Systems, Inc. (CHS); Universal Health Service (UHS); Hospital Corporation of America (HCA); Surgery Care Affiliates (SCA); SurgCenter Development; Covenant Surgical Partners; and Regent Surgical Health. Further key findings from the study suggest: • The freestanding ownership segment accounted for the highest market share in 2018 owing to maximum professional control over clinical environment, high profitability, and quality of care delivered to patients • High government expenditure for the development of ambulatory surgery centers to reduce treatment costs and increase accessibility along with better reimbursement policies for procedures performed at ASC are driving the market growth • Key suppliers operating in the U.S. gastroenterology ambulatory surgery center market are Cardinal Health, Medtronic PLC, Ethicon (Johnson & Johnson), Boston Scientific, Olympus, Becton Dickinson (BD), Hill-Rom Holdings, GE Healthcare, Koninklijke Philips N.V., and Cook Medical
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Ownership
1.1.2 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR's internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity flow approach
1.6.2 Volume price analysis (Model 2)
1.6.2.1 Approach 2: Volume price analysis
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.2 Objective - 1
1.9.2 Objective - 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Ownership
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Market Segmentation
3.2.1 Analysis
3.3 Penetration & Growth Prospect Mapping
3.3.1 Penetration analysis
3.4 Regulatory & Reimbursement Framework
3.4.1 Ambulatory services regulations in the U.S.
3.5 Technological Trends and Recent Advancements
3.6 Market Dynamics
3.6.1 Market driver analysis
3.6.1.1 Cost-effectiveness due to increase in reimbursement rate
3.6.1.2 Increasing utilization of technology for minimally invasive procedures
3.6.2 Market restraint analysis
3.6.2.1 Safety issues and regulatory concerns
3.6.2.2 Operational uncertainty
3.7 U.S. Gastroenterology Ambulatory Surgery Center (ASC) Market: Business Environment Analysis Tools
3.7.1 U.S. gastroenterology Ambulatory Surgery Center (ASC) Market: PORTER's Five Forces Analysis
3.7.2 U.S. gastroenterology Ambulatory Surgery Center (ASC) Market: PESTLE Analysis
3.7.3 Major deals & strategic alliances analysis
3.7.3.1 Mergers & acquisitions and joint ventures
3.7.3.2 Licensing & partnerships and technology collaborations
Chapter 4 U.S. Gastroenterology Ambulatory Surgery Center (ASC) Market: Ownership Analysis
4.1 U.S. Gastroenterology Ambulatory Surgery Center (ASC) Ownership Market Share Analysis, 2018 & 2026
4.2 U.S. Gastroenterology Ambulatory Surgery Centers Ownership Market: Segment Dashboard:
4.3 Market Size & Forecasts and Trend Analysis, Ownership Segment 2015 to 2026 (USD Million)
4.3.1 Hospital-affiliated
4.3.1.1 Hospital-affiliated market, 2015 - 2026 (USD Million)
4.3.2 Freestanding
4.3.2.1 Freestanding market, 2015 - 2026 (USD Million)
4.3.3 Corporation-owned
4.3.3.1 Corporation-owned market, 2015 - 2026 (USD Million)
4.3.4 Others
4.3.4.1 Others market, 2015 - 2026 (USD Million)
Chapter 5 U.S. Gastroenterology Ambulatory Surgery Center (ASC) Market: Regional Analysis
5.1 U.S.
5.1.1 U.S. gastroenterology ambulatory surgery center market, 2015 - 2026 (USD Million)
Chapter 6 Competitive Analysis
6.1 Strategic Framework/Competition Categorization (Key innovators, market leaders, emerging players)
6.2 Vendor Landscape
6.2.1 Company market position analysis, by manufacturer (Overall revenue, product portfolio, geographic presence, employee strength, & strategic initiatives,)
6.2.1.1 Analysis
6.2.2 Company market position analysis, by service provider (Market presence, service portfolio, employee strength & strategic initiatives)
6.2.2.1 Analysis
6.3 Company Profiles
6.3.1 By manufacturer
6.3.1.1 Cardinal Health
6.3.1.1.1 Company overview
6.3.1.1.2 Financial performance
6.3.1.1.3 Product benchmarking
6.3.1.1.4 Strategic initiatives
6.3.1.1.5 SWOT analysis
6.3.1.2 Boston Scientific Corporation
6.3.1.2.1 Company overview
6.3.1.2.2 Financial performance
6.3.1.2.3 Product benchmarking
6.3.1.2.4 Strategic initiatives
6.3.1.2.5 SWOT analysis
6.3.1.3 GE Healthcare
6.3.1.3.1 Company overview
6.3.1.3.2 Financial performance
6.3.1.3.3 Product benchmarking
6.3.1.3.4 Strategic initiatives
6.3.1.3.5 SWOT analysis
6.3.1.4 Koninklijke Philips N.V.
6.3.1.4.1 Company overview
6.3.1.4.2 Financial performance
6.3.1.4.3 Product benchmarking
6.3.1.4.4 Strategic initiatives
6.3.1.4.5 SWOT analysis
6.3.1.5 Cook Medical
6.3.1.5.1 Company overview
6.3.1.5.2 Financial overview
6.3.1.5.3 Product benchmarking
6.3.1.5.4 Strategic initiatives
6.3.1.5.5 SWOT analysis
6.3.1.6 Hill-Rom Holding Inc
6.3.1.6.1 Company overview
6.3.1.6.2 Financial performance
6.3.1.6.3 Product benchmarking
6.3.1.6.4 Strategic initiatives
6.3.1.6.5 SWOT analysis
6.3.1.7 Medtronic PLC
6.3.1.7.1 Company overview
6.3.1.7.2 Financial performance
6.3.1.7.3 Product benchmarking
6.3.1.7.4 Strategic initiatives
6.3.1.7.5 SWOT analysis
6.3.1.8 Becton, Dickinson and Company
6.3.1.8.1 Company overview
6.3.1.8.2 Financial performance
6.3.1.8.3 Product benchmarking
6.3.1.8.4 Strategic initiatives
6.3.1.8.5 SWOT anlysis
6.3.1.9 Johnson & Johnson Services, Inc.
6.3.1.9.1 Company overview
6.3.1.9.2 Financial performance
6.3.1.9.3 Product benchmarking
6.3.1.9.4 Strategic initiatives
6.3.1.9.5 SWOT analysis
6.3.1.10 Olympus Corporation
6.3.1.10.1 Company overview
6.3.1.10.2 Financial performance
6.3.1.10.3 Product benchmarking
6.3.1.10.4 Strategic initiatives
6.3.1.10.5 SWOT analysis
6.3.2 By service provider
6.3.2.1 Envision Healthcare Corporation
6.3.2.1.1 Company overview
6.3.2.1.2 Financial performance
6.3.2.1.3 Services benchmarking
6.3.2.1.4 Strategic initiatives
6.3.2.1.5 SWOT analysis
6.3.2.2 Surgical Care Affiliates, Inc. (SCA)
6.3.2.2.1 Company overview
6.3.2.2.2 Financial performance
6.3.2.2.3 Services benchmarking
6.3.2.2.4 Strategic initiatives
6.3.2.2.5 SWOT analysis
6.3.2.3 Surgery Partners
6.3.2.3.1 Company overview
6.3.2.3.2 Financial performance
6.3.2.3.3 Services benchmarking
6.3.2.3.4 Strategic initiatives
6.3.2.3.5 SWOT analysis
6.3.2.4 Tenet Healthcare Corporation
6.3.2.4.1 Company overview
6.3.2.4.2 Financial performance
6.3.2.4.3 Services benchmarking
6.3.2.4.4 Strategic initiatives
6.3.2.4.5 SWOT analysis
6.3.2.5 Universal Health Services, Inc.
6.3.2.5.1 Company overview
6.3.2.5.2 Financial performance
6.3.2.5.3 Services benchmarking
6.3.2.5.4 Strategic initiatives
6.3.2.5.5 SWOT analysis
6.3.2.6 Community Health Systems, Inc.
6.3.2.6.1 Company overview
6.3.2.6.2 Financial performance
6.3.2.6.3 Services benchmarking
6.3.2.6.4 Strategic initiatives
6.3.2.6.5 SWOT analysis
6.3.2.7 HCA Healthcare, Inc.
6.3.2.7.1 Company overview
6.3.2.7.2 Financial performance
6.3.2.7.3 Services benchmarking
6.3.2.7.4 Strategic initiatives
6.3.2.7.5 SWOT analysis
6.3.2.8 Covenant Surgical Partners
6.3.2.8.1 Company overview
6.3.2.8.2 Financial performance
6.3.2.8.3 Services benchmarking
6.3.2.8.4 Strategic initiatives
6.3.2.9 SurgCenter Development
6.3.2.9.1 Company overview
6.3.2.9.2 Financial performance
6.3.2.9.3 service benchmarking
6.3.2.9.4 Strategic initiatives
6.3.2.10 Regent Surgical Health
6.3.2.10.1 Company overview
6.3.2.10.2 Financial performance
6.3.2.10.3 Services benchmarking
6.3.2.10.4 Strategic initiatives
Chapter 7 Recommendations
List of Tables TABLE 1 List of secondary sources TABLE 2 List of abbreviations TABLE 3 Technological trends and recent advancements TABLE 4 CPT reimbursement 2017 TABLE 5 List of new CPT codes TABLE 6 Merger & acquisitions and joint ventures TABLE 7 Licensing & partnerships and technology collaborations TABLE 8 List of few ambulatory surgery centers in the U.S. TABLE 9 U.S. gastroenterology ambulatory surgery center (ASC) market, by ownership, 2015 - 2026 (USD Million)
List of Figures FIG. 1 Market research process FIG. 2 Information procurement FIG. 3 Primary research pattern FIG. 4 Market research approaches FIG. 5 Value chain based sizing & forecasting FIG. 6 QFD modelling for market share assessment FIG. 7 Market formulation & validation FIG. 8 U.S. gastroenterology ambulatory surgery center market outlook, 2018 FIG. 9 U.S. gastroenterology ambulatory surgery center market segmentation FIG. 10 Penetration & growth prospect mapping FIG. 11 Market driver relevance analysis (Current & future impact) FIG. 12 Market restraint relevance analysis (Current & future impact) FIG. 13 U.S. gastroenterology ambulatory surgery center market: Porter's five forces model FIG. 14 U.S. gastroenterology ambulatory surgery center market - PESTLE analysis FIG. 15 U.S. gastroenterology ambulatory surgery centers ownership: Movement analysis, 2018 & 2026 FIG. 16 U.S. gastroenterology ambulatory surgery center ownership market: Segment dashboard FIG. 17 Hospital-affiliated market, 2015 - 2026 (USD Million) FIG. 18 Freestanding market, 2015 - 2026 (USD Million) FIG. 19 Corporation-owned market, 2015 - 2026 (USD Million) FIG. 20 Others market, 2015 - 2026 (USD Million) FIG. 21 U.S. gastroenterology ambulatory surgery center market, 2015 - 2026 (USD Million) FIG. 22 Strategy framework/Competition categorization FIG. 23 Company market position analysis, by manufacturer (Overall revenue, product portfolio, geographic presence, employee strength, & strategic initiatives) FIG. 24 Company market position analysis, by service provider (Market presence, service portfolio, employee strength, & strategic initiatives)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
